The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 37 | — | 20.1x | Near average | |
Growth | 17 | -45.5% | 5.6% | Below average | |
Quality | 39 | -71.0% | 7.6% | Near average | |
Safety | 30 | 0.6x | 0.4x | Below average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Voyager Therapeutics, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Voyager Therapeutics, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Analyst data shows remarkable stability in the target price for VYGR at an average of 14.4 dollars, with this consensus remaining steady over the past 30 days despite the stock's price fluctuations. The variance between the low (8 dollars) and the high (18 dollars) indicates a gap in risk assessment; however, the concentration of the Median at 18 dollars reflects strong optimism among the majority of the seven analysts covering the stock.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.